Shares of Neovasc Inc. (TSE:NVCN – Get Rating) traded down 0.5% on Friday . The stock traded as low as C$40.15 and last traded at C$40.15. 1,156 shares changed hands during trading, a decline of 55% from the average session volume of 2,566 shares. The stock had previously closed at C$40.35.
Neovasc Trading Down 0.5 %
The company has a current ratio of 8.44, a quick ratio of 8.04 and a debt-to-equity ratio of 44.86. The firm has a market capitalization of C$110.81 million, a P/E ratio of -2.33 and a beta of 2.01. The firm has a 50-day moving average of C$37.07 and a two-hundred day moving average of C$20.30.
Neovasc Company Profile
Neovasc Inc, a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina.
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.